- Home
- EOLS vs KAZR Comparison
EOLS vs KAZR Comparison
Compare EOLS & KAZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EOLS | KAZR |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Engineering & Construction |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 454.4M | 398.1M |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | EOLS | KAZR |
|---|---|---|
| Price | $5.71 | $2.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.50 | N/A |
| AVG Volume (30 Days) | ★ 776.9K | 159.4K |
| Earning Date | 05-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.23 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $297,176,000.00 | N/A |
| Revenue This Year | $13.27 | N/A |
| Revenue Next Year | $17.62 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.61 | N/A |
| 52 Week Low | $3.86 | $2.50 |
| 52 Week High | $10.20 | $3.20 |
Technical Indicators
Market Signals| Indicator | EOLS | KAZR |
|---|---|---|
| Relative Strength Index (RSI) | 31.66 | 33.83 |
| Support Level | $4.02 | N/A |
| Resistance Level | $7.16 | $3.07 |
| Average True Range (ATR) | 0.33 | 0.26 |
| MACD | -0.17 | -0.04 |
| Stochastic Oscillator | 11.95 | 8.06 |
Price Performance
Historical ComparisonAbout EOLS Evolus Inc.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.